Castle Creek Arbitrage’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Castle Creek Arbitrage’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-600,000	Closed	-$6.03M	–	818
2022 Q3	$6.03M	Hold	600,000	–	–	0.33%	85
2022 Q2	$6.01M	Hold	600,000	–	–	0.33%	88
2022 Q1	$6.06M	Hold	600,000	–	–	0.31%	93
2021 Q4	$6.05M	Buy	+600,000	New	+$6.07M	0.3%	92

Other funds holding LVACU

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Castle Creek Arbitrage's LVACU Position: Q4 2022 in Review

Castle Creek Arbitrage sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q4 2022, closing a stake of 600,000 shares — an estimated $6.03M sold.

Castle Creek Arbitrage first reported a position in LVACU in Q4 2021 and held it in 4 quarters. The position peaked at $6.06M in Q1 2022. 6 funds tracked by Wall St. Rank hold LVACU as of Q4 2022.

Castle Creek Arbitrage reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q4 2022 after selling out during the quarter.
Castle Creek Arbitrage sold 600,000 LAVA Medtech Acquisition Corp. Unit shares in Q4 2022, an estimated $6.03M.
Castle Creek Arbitrage first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 4 quarters.
Castle Creek Arbitrage's LAVA Medtech Acquisition Corp. Unit position peaked at $6.06M in Q1 2022.
6 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q4 2022.

Based on Castle Creek Arbitrage's 13F filing for Q4 2022, filed 14 Feb 2023.